Filter by
Filter by
Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer.
This retrospective study analyzing 16 patients with locally recurrent breast cancer who underwent re-irradiation to the chest wall with PBT to the median dose...
A population-based assessment of proton beam therapy utilization in California.
Based on data from California Cancer Registry, this study reported that of the 2,499,510 people with a cancer diagnosis during the study period, 578,632 (23%)...
End-of-Range Radiobiological Effect on Rib Fractures in Patients Receiving Proton Therapy for Breast Cancer.
Published in the Red Journal, this MGH study looked into the possible causes to the high rate of rib fracture that reported in the recent MGH prospective trial...
Acute Toxicities After Proton Beam Therapy Following Breast-Conserving Surgery for Breast Cancer: Multi-institutional Prospective PCG Registry Analysis. This is the report of the prospective multi-institutional Proton Collaborative Group registry study.
82 patients received PBT and their adverse events (AEs) were recorded prospectively at each institution. Median follow-up was 8.1 months. Median dose was 50.4...
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
This study estimated secondary cancer risks for 23 mediastinal lymphoma patients treated with PBT in comparison with helical photon IMRT re-plans. PBT was...
Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.
This study compared tangential 3D-CRT and VMAT to PBS proton therapy in secondary cancer risk (SCR) for the lungs and for contralateral breast. PBS PT was...